Skip to main content
. 2013 Oct 14;13:476. doi: 10.1186/1471-2407-13-476

Figure 6.

Figure 6

Serum HA predicts ovarian cancer progression-free survival and overall survival. A. Patients with high serum HA (> 50 μg/ml, n = 15) had a significantly reduced progression-free survival compared to patients with low serum HA (≤50 μg/mL, n = 62), log rank statistic = 6.035, P = 0.014. B. Patients with high serum HA (> 50 μg/ml, n = 16) had a significantly reduced overall survival compared to patients with low serum HA (≤50 μg/mL, n = 67), log rank statistic = 4.39, P = 0.036.